Biome Diagnostics (BiomeDx®), an Austrian leader in microbiome technologies, is at the forefront of improving healthcare. By focusing on gut health’s impact on overall well-being, BiomeDx develops solutions for healthcare challenges, including cancer treatment, digestive health, and personalized nutrition. This year, BiomeDx is showcasing their latest innovations at Arab Health 2025, the largest healthcare event in the Middle East, held from January 27-30 at the Dubai World Trade Centre.

Arab Health 2025: A Platform for Microbiome Innovation

Arab Health 2025 celebrates its 50th anniversary, making it a key moment for BiomeDx to present its groundbreaking solutions. Furthermore, this event gives BiomeDx the chance to share insights and connect with healthcare leaders, advancing microbiome science. At Arab Health 2025, BiomeDx will be located at Hall 8, Booth A19. Here, they will demonstrate how microbiome data can improve healthcare outcomes, especially for cancer patients.

Transforming Healthcare with Gut Microbiome Insights

BiomeDx’s product line focuses on the gut microbiome and offers solutions for diverse health concerns. Their work is based on the fact that optimizing the microbiome can lead to better patient outcomes. Moreover, this applies to various use cases e.g. cancer treatment, food intolerances, or general wellness.

A key product is the myBioma Test, a home-based test that helps individuals analyze their gut bacteria and understand their digestive health. The test provides valuable insights into how gut microbiomes affect well-being. Personalized dietary recommendations are then offered to improve gut and overall health in the long run.

For cancer patients, BiomeDx developed BiomeOne®, a diagnostic test focused on immunotherapy response. By analyzing a stool sample, BiomeOne® identifies the patient’s microbiome signature and predicts the likelihood of a positive immunotherapy response. Subsequently, this precision helps doctors personalize treatment plans, improving treatment efficacy and reducing risks.

Prebiotic Innovations for Gut Health

BiomeDx also offers myBioma Balance, a prebiotic drink designed to support gut health. Prebiotics are key for nurturing beneficial gut bacteria, improving digestion, and overall health. With myBioma Balance, BiomeDx certainly helps individuals maintain a balanced gut microbiome, boosting immune function, digestion, and mood.

A Promising Future for Personalized Healthcare

The European Super Angels Club (ESAC) proudly supports BiomeDx in reshaping healthcare. Their microbiome-based innovations open new doors for precision medicine, benefiting cancer care, digestive health, and nutrition. With products like BiomeOne® and the myBioma Test, BiomeDx is playing a vital role in advancing personalized healthcare and improving patient outcomes worldwide.

Visit BiomeDx at Arab Health 2025, Hall 8, Booth A19, to discover their revolutionary microbiome-based technologies and see how they are shaping the future of healthcare.